Treatment of seborrheic dermatitis: a comprehensive review

  title={Treatment of seborrheic dermatitis: a comprehensive review},
  author={Luis J Borda and Marina Perper and Jonette E. Keri},
  journal={Journal of Dermatological Treatment},
  pages={158 - 169}
Abstract Seborrheic dermatitis (SD) is a chronic, recurring inflammatory skin disorder that manifests as erythematous macules or plaques with varying levels of scaling associated with pruritus. The condition typically occurs as an inflammatory response to Malassezia species and tends to occur on seborrheic areas, such as the scalp, face, chest, back, axilla, and groin areas. SD treatment focuses on clearing signs of the disease; ameliorating associated symptoms, such as pruritus; and… 

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis

Features of management of patients with seborrheic dermatitis

In the treatment of persistent and long-term forms of seborrheic dermatitis, systemic antifungal agents and systemic retinoids are used, which allow for a long time to achieve regression of skin rashes and significantly improve the quality of life of the patient.

Seborrheic dermatitis and its relationship with Malassezia spp

The current knowledge on the disease’s pathophysiology and the role of Malassezia sp.

Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options

Effective treatment for older adults must take into account changes in lifestyle and metabolism that occur with aging, and topical treatment is the gold standard, but oral therapy may be required in certain cases.

Skin microbiome alterations in seborrheic dermatitis and dandruff: A systematic review

A systematic review of research studies published in English between 1 January 2000 and 31 December 2020 to investigate the skin microbiome alterations in patients with Seborrheic dermatitis and dandruff demonstrated an increased Malassezia restricta/MalasseZia globosa ratio and a reduction in the Cutibaterium/Staphylococcus ratio in the setting of SD/DF.

Seborrheic dermatitis—Looking beyond Malassezia

It is proposed that intrinsic host factors, such as changes in the amount or composition of sebum and/or defective epidermal barrier, rather than Malassezia, may form the basis of SD pathobiology.

Novel Non-Steroidal Facial Cream Demonstrates Antifungal and Anti-Inflammatory Properties in Ex Vivo Model for Seborrheic Dermatitis

The proposed ex vivo model for SEBD could be a useful tool to evaluate topical antifungal treatments and may be helpful in the management of SEBD.

A Meta-Analysis on the Effectiveness of Sertaconazole 2% Cream Compared with Other Topical Therapies for Seborrheic Dermatitis

Treating patients with seborrheic dermatitis with sertaconazole 2% cream may represent an efficient alternative therapy for patients with SD.

Malassezia infections : Diagnostic perspective and treatment approach in Africa

There is need for improvement in diagnostic techniques used for these diseases and more research is required in order to ascertain the actual prevalence of these diseases in Africa.

Successful treatment of erythematous‐squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: Our experience in 25 patients

The efficacy and the absence of side effects with the treatment make this magistral formula an adequate therapeutic option for these dermatoses.



Treating seborrheic dermatitis: review of mechanisms and therapeutic options.

  • N. Bhatia
  • Medicine
    Journal of drugs in dermatology : JDD
  • 2013
Although the needs of the scalp, face and chest are different, as are the variations in skin types, the fundamental mechanisms of the inflammatory process are often the same and the ideal mechanisms of action of therapies should be directed as such.

Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.

Low-Dose Isotretinoin for Seborrhoeic Dermatitis

  • M. Rademaker
  • Medicine
    Journal of cutaneous medicine and surgery
  • 2017
A retrospective review of patients with seborrhoeic dermatitis treated with isotretinoin over a 5-year period found no significant difference in response, as determined by the presence of concomitant disease (acne, folliculitis, or rosacea).

Adult seborrheic dermatitis: a status report on practical topical management.

  • J. D. Del Rosso
  • Medicine, Biology
    The Journal of clinical and aesthetic dermatology
  • 2011
A variety of treatments are available including topical corticosteroids, topical antifungal agents, topical calcineurin inhibitors, and more recently, a nonsteroidal "device "cream in the United States, focusing on the adult population.

Seborrheic dermatitis: an update.

Current knowledge on the etiopathogenesis and therapy of adult seborrheic dermatitis is summarized in a review of treatment modalities available.

Seborrheic Dermatitis and Dandruff: A Comprehensive Review

The current knowledge on SD and dandruff is summarized, including epidemiology, burden of disease, clinical presentations and diagnosis, treatment, genetic studies in humans and animal models, and predisposing factors.

Benzoyl peroxide in seborrheic dermatitis.

The treatment of patients with seborrheic dermatitis of the face with benzoyl peroxide at a concentration of 2.5% in a base was strikingly effective in all but two patients.

Fluconazole and its place in the treatment of seborrheic dermatitis--new therapeutic possibilities.

Fluconazole treatment in patients with seborrheic dermatitis proves to be successful, effective and safe.

Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study.

Initial treatment with itraconazole was beneficial in patients with moderate to severe seborrheic dermatitis and significant improvement was reported in three clinical parameters: erythema, scaling, itching.

Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials

Pimecrolimus 1% cream appears to be a well-tolerated and effective treatment for seborrheic dermatitis and has comparable efficacy, in terms of decreasing severity of erythema, scaling and pruritus to the standard treatments: topical corticosteroids and antimycotics.